|
The partnership aims to speed up early-phase clinical development and provide new therapies to patients.
|
 |
|
Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its more than 40-strong drug pipeline.
|
|
|
SNV4818 is an oral drug and is presently being assessed in an ongoing Phase I/II trial for breast cancer.
|
|
|
Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it vulnerable to biosimilar competition in these regions.
|
|
|
At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup succeed.
|
|
